{"id":150942,"date":"2023-08-02T11:00:03","date_gmt":"2023-08-02T15:00:03","guid":{"rendered":"https:\/\/44.250.171.167\/?p=150942"},"modified":"2023-08-02T11:00:05","modified_gmt":"2023-08-02T15:00:05","slug":"jagsonpal-pharmaceuticals-ltd-q1fy24-156-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/jagsonpal-pharmaceuticals-ltd-q1fy24-156-rise-in-profits\/","title":{"rendered":"Jagsonpal Pharmaceuticals Ltd Q1FY24; 156% rise in Profits"},"content":{"rendered":"<p>Jagsonpal Pharmaceuticals Ltd is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. It has operations in India and caters to both domestic and international markets.<\/p>\n<p><strong>Financial Results:<\/strong><\/p>\n<ul>\n<li>Jagsonpal Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b960.15 Crores down from \u20b960.60 Crore year on year, a fall of 0.74%.<\/li>\n<li>Total Expenses for Q1FY24 of \u20b952.06 Crores down from \u20b953.62 Crores year on year, a fall of 2.91%.<\/li>\n<li>Consolidated Net Profit of \u20b97.48 Crores up 156.16% from \u20b92.92 Crores in the same quarter of the previous year.<\/li>\n<li>The Earnings per Share is \u20b92.86, up 157.66% from \u20b91.11 in the same quarter of the previous year.<\/li>\n<\/ul>\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93-839x1024.png\" alt=\"\" class=\"wp-image-150943\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish. <br \/>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>","protected":false},"excerpt":{"rendered":"<p>Jagsonpal Pharmaceuticals Ltd is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. It has operations in India and caters to both domestic and international markets. Financial Results: Jagsonpal Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b960.15 Crores down from \u20b960.60 Crore year on year, a fall of 0.74%. Total Expenses for [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-150942","post","type-post","status-publish","format-standard","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":153153,"url":"https:\/\/alphastreet.com\/india\/glenmark-pharmaceuticals-ltd-q1fy24-18-fall-in-profits\/","url_meta":{"origin":150942,"position":0},"title":"Glenmark Pharmaceuticals Ltd Q1FY24; 18% fall in Profits","author":"Hardik Bhandare","date":"August 14, 2023","format":false,"excerpt":"Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries. Financial Results: Glenmark Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b93,402.00 Crores up from \u20b92,777.00 Crore year on year, a rise of 22.51%. Total Expenses for Q1FY24\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":154288,"url":"https:\/\/alphastreet.com\/india\/balaxi-pharmaceuticals-ltd-q1fy24-20-fall-in-revenue\/","url_meta":{"origin":150942,"position":1},"title":"Balaxi Pharmaceuticals Ltd Q1FY24; 20% fall in Revenue","author":"Divyansh_Kasana","date":"August 17, 2023","format":false,"excerpt":"Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines. Financial Results: Balaxi Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b966.00 Crores down from \u20b983.00 Crore year on year, a fall of 20.48%. Total Expenses for Q1FY24 of \u20b957.00 Crores down\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151061,"url":"https:\/\/alphastreet.com\/india\/sun-pharmaceuticals-industries-ltd-q1fy24-4-fall-in-profits\/","url_meta":{"origin":150942,"position":2},"title":"Sun Pharmaceuticals Industries Ltd Q1FY24; 4% fall in Profits","author":"Chirag Gupta","date":"August 3, 2023","format":false,"excerpt":"Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-130.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-130.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-130.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-130.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-130.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-130.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152269,"url":"https:\/\/alphastreet.com\/india\/kopran-ltd-q1fy24-64-fall-in-profits\/","url_meta":{"origin":150942,"position":3},"title":"Kopran Ltd Q1FY24; 64% fall in Profits","author":"Hardik Bhandare","date":"August 10, 2023","format":false,"excerpt":"Kopran Ltd. is an integrated Pharmaceutical Company, committed to manufacture and supply International Quality Formulations and Active Pharmaceutical Ingredients worldwide. Financial Results: Kopran Ltd reported Revenues for Q1FY24 of \u20b9117.00 Crores down from \u20b9125.62 Crore year on year, a fall of 6.86%. Total Expenses for Q1FY24 of \u20b9115.78 Crores down\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151727,"url":"https:\/\/alphastreet.com\/india\/sms-pharmaceuticals-ltd-q1fy24-110-rise-in-revenue\/","url_meta":{"origin":150942,"position":4},"title":"SMS Pharmaceuticals Ltd Q1FY24; 110% rise in Revenue","author":"Chirag Gupta","date":"August 8, 2023","format":false,"excerpt":"SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates. Financial Results: SMS Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b9135.34 Crores up from \u20b964.39 Crore year on year, a rise of 110.19%. Total Expenses for Q1FY24 of \u20b9123.17 Crores up\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-351.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152109,"url":"https:\/\/alphastreet.com\/india\/iol-chemicals-31-rise-in-profits\/","url_meta":{"origin":150942,"position":5},"title":"IOL Chemicals &#038; Pharmaceuticals Ltd Q1FY24; 31% rise in Profits","author":"Hardik Bhandare","date":"August 9, 2023","format":false,"excerpt":"IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market. Financial Results IOL Chemicals & Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b9563.00 Crores down from \u20b9565.00 Crore year on year, a\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-479.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-479.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-479.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-479.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-479.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-479.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/150942","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=150942"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/150942\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=150942"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=150942"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=150942"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}